Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with obesity or overweight (VISTA): a multicentre, phase 2, randomised, placebo-controlled clinical trial. (linkinghub.elsevier.com)

Authors: Davies MJ … Sjostrom CD Journal: The Lancet Published: 2026-06-20 DOI: https://doi.org/10.1016/S0140-6736(26)00748-8